Monitoring and assessment: Over the next one to two weeks, well stay in close contact with you to gauge your response to the starting dose
We observed a reduction in insulin, glucose, HOMA-IR, triglyceride, leptin, and several oxidative stress and inflammation biomarker levels and an increase in high-density lipoprotein and adiponectin levels at the end of 4 th week during 4-week intermittent fasting, however, these parameters did not reach statistical significance
The World Health Organization issued a warning in June 2025 that semaglutide drugs like Ozempic may rarely cause NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy), prompting Ozempic vision loss lawsuits and advising patients to seek immediate medical care if they experience rapid vision changes
Motivational Interviewing : Motivational interviewing helps clients navigate challenges and stick to their fasting protocols
10.1210/clinem/dgaa285 J Clin Endocrinol Metab